Skip to Main Content

Paper Details

Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
Clin Cardiol
4
2022
ALI, Acetylsalicylic Acid, CASPAR, CV death, Clopidogrel, DAPT, IS, MI, PAD, Peripheral Arterial Disease, UILR, acute limb ischemia, amputation, aspirin, factor Xa, myocardial infarction, occluded coronary arteries, patients, peripheral artery disease, rivaroxaban, streptokinase, stroke, tissue plasminogen activator
Author NameAffiliation
Manesh R PatelDuke Clinical Research Institute, Duke University Medical Center
Sonia S AnandPopulation Health Research Institute, McMaster University
  • 1 - 2

Datasets

Release 1.2